ITU Experts Group

Thierry Zylberberg, Executive Vice President Orange, General Manager of Orange Healthcare

September 2012

2

agenda

part 1frameworks for m-health

part 2concrete case

part 3challenges and opportunities

3

reality…

Worldwide, between 2010 and 2050,

people aged 60 and more : +100 %1

People aged 80 and more : +100 %1

Between 2000 and 2050, share of the

dependent population: + 25 % in OECD countries

Spending for seniors to double or more by 2050,

says OECD

Chronic Disease Direct costs:Asthma: b$17.7 in Europe3

Diabetes: b$92 in USA3

Heart Failure: b$37 in USA4

Half of Brazil population said to have at least 1 chronic disease

In India, by 2015, 59% ofthe total deaths would

be due to NCDs

Healthcare expenditure in OECD countries +5%/year

France : 11% of GDPUSA : 15,3% of GDPGermany : 10,7% of

GDP says OCED

~30% of drugs of any given medicine can

be fake in Africa2

1 : accord the WHO, 20112 : according the WHO. (Source: The Times-UK, February, 2009)3: IDATE, sur la base du WHO 2009 ; OECD 2009 ; US Census 2009 ; Eurostat 20094: Home Monitoring for Heart Failure Management, Anh L. Bui, MD, Gregg C. Fonarow, MD Los Angeles, California, Journal of the American College of Cardiology Vol. 59, No. 2, 2012

1- frameworks for m-health

4

1- frameworks for m-health

technology…

low costs phenotypes

big datatechnologies

web 2.0, Internet

technologies

always ontechnologies

predictivemedicine

multiple factorstreatment or

diagnosis

be with the patienteverywhere,

anytime

patientempowerment

5

1- frameworks for m-health

Press & Portals

Web 2.0

CRM

New business model

Disruptive technologies

…in a complex ecosystem…

6

…a framework

health

professionals

patients

&

health professionals

patients

&

patients

BtoB

BtoGBtoC

business

model

medical data

compliance

medical medical consumerusage

Orange Healthcare©

Bto BG C

2

1- frameworks for m-health

7

business modelyet to

be found

healthaccess

healthefficiency

new busine

ss model

stablebusines

smodel

Cloud-Imagery

Drugs authentification

Health-line

ConnectedHospital

CDRMCloud-EHR

Health data hosting

Remote consultation (video

conf.)

DiabeticPatient follow

up

Appointment reminder

...another framework

1- frameworks for m-health

Toll-free emergency

Health surveys surveillance

8

Orange Value Chain

Health Applicati

ons

Healthcare ecosystem

Health “Computing”

(hosting)

PartnersPartners

Patients

Medical Devices

Consulting, Integration

M2M, International backbones &

Last mile

Global Integration, Helpdesk, services to end users

Specific developments (Security,

portals)

e-health, an ecosystem in mutation requires cooperation

1- frameworks for m-health

9

case 1 of partnership: Sanofi and Orange

2- concrete case

10

DiabeTIC Platform. Bidirectional communication between HCP & Patients

Mobile Computer

Patients with BGStar or iBGStar

Patient with other BGMs

Storage and analysis

HCPPATIENT

DNE

Available to all patients (not only i/BGStar patients)

2- concrete case

11 Orange Healthcare – TWC 2011

case 2 of partnership: mPedigree and Orange

2- concrete case

12

SMS based solution allowing to check if taken drug is counterfeit or authentic.

Easy-to-use solution, immediate response

Implemented in Kenya

counterfeit medicine solutionOrange and mPedigree are fighting counterfeit medicines

2- concrete case

13

challenges and opportunities

3- challenges and opportunities

1st challenge: business model

B2G or B2B2C or

B2C?

How can consumers be educated about and persuaded to use such a service?

How can pharmacist be incentivized

to positively promote such a service?Who will fund services?

Can pharmas finance services? Why?

Does a government need to constrain the installation of a

service ?

Is the system open to abuse – such as counterfeiters providing bogus SMS

checking numbers themselves?

What other kinds of similar services

could be developed?

3- challenges and opportunities

15

2nd challenge: dilution of responsibility, value chain complexity

Mobile Computer

Patients with BGStar or iBGStar

Patient with other BGMs

Storage and analysis

HCPPATIENT

DNE

connectivity

3- challenges and opportunities

16

3rd challenge: regulation

3- challenges and opportunities

17

Thank you